From L-R: Quibim COO Alberto Valiente, CEO Ángel Alberich-Bayarri, VP Finance & Business Intelligence Javier Sáez. Photo by Quibim, S.L. As the saying goes, a picture is worth 1,000 words. But ...

Sanara MedTech has a 12 month low of $26.00 and a 12 month high of $40.75. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.23 and a quick ratio of 2.02.

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Sanara MedTech (SMTI – Research Report), retaining the price target of $50.00. Yi Chen has given his Buy rating due to a combination ...

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and ...

FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we ...

Sanara MedTech Inc. Posts Strong Growth in Q4 and Full Year 2024 Results Posted by MarketBeat News on Jan 22nd, 2025 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits ...